000 01861 a2200553 4500
005 20250515164136.0
264 0 _c20090729
008 200907s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/j.transproceed.2009.01.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchneeberger, S
245 0 0 _aAlemtuzumab: key for minimization of maintenance immunosuppression in reconstructive transplantation?
_h[electronic resource]
260 _bTransplantation proceedings
_cMar 2009
300 _a499-502 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlemtuzumab
650 0 4 _aAmputation, Surgical
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntibodies, Neoplasm
_xtherapeutic use
650 0 4 _aArm
_xtransplantation
650 0 4 _aAustria
650 0 4 _aFemale
650 0 4 _aForearm
_xsurgery
650 0 4 _aFunctional Laterality
650 0 4 _aHand Transplantation
650 0 4 _aHistocompatibility Testing
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
_xmethods
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlastic Surgery Procedures
_xmethods
650 0 4 _aSpain
650 0 4 _aTransplantation Immunology
650 0 4 _aTransplantation, Homologous
_ximmunology
650 0 4 _aUnited States
650 0 4 _aYoung Adult
700 1 _aLandin, L
700 1 _aKaufmann, C
700 1 _aGorantla, V S
700 1 _aBrandacher, G
700 1 _aCavadas, P
700 1 _aLee, W P A
700 1 _aBreidenbach, W C
700 1 _aMargreiter, R
773 0 _tTransplantation proceedings
_gvol. 41
_gno. 2
_gp. 499-502
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2009.01.018
_zAvailable from publisher's website
999 _c18765523
_d18765523